<h4>Background</h4>Uncertainty exists regarding the clinical relevance of programmed cell death ligand 1 (PD-L1) expression in breast cancer.<h4>Methods</h4>A systematic review was performed in accordance with PRISMA guidelines. Here, CD274 is linked to breast carcinoma.